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ABSTRACT
The molecular mechanism of human mitochondrial
translation has yet to be fully described. We are par-
ticularly interested in understanding the process of
translational termination and ribosome recycling in
the mitochondrion. Several candidates have been
implicated, for which subcellular localization and
characterization have not been reported. Here,
we show that the putative mitochondrial recycling
factor, mtRRF, is indeed a mitochondrial protein.
Expression of human mtRRF in fission yeast
devoid of endogenous mitochondrial recycling
factor suppresses the respiratory phenotype. Fur-
ther, human mtRRF is able to associate with Escher-
ichia coli ribosomes in vitro and can associate with
mitoribosomes in vivo. Depletion of mtRRF in
human cell lines is lethal, initially causing profound
mitochondrial dysmorphism, aggregation of mitori-
bosomes, elevated mitochondrial superoxide pro-
duction and eventual loss of OXPHOS complexes.
Finally, mtRRF was shown to co-immunoprecipitate
a large number of mitoribosomal proteins attached
to other mitochondrial proteins, including putative
members of the mitochondrial nucleoid.
INTRODUCTION
Mitochondria play a vital role in a wide variety of cellular
processes in eukaryotic cells. They possess their own geno-
mic DNA (mtDNA) that encodes 13 proteins, along with
22 tRNA and 2 ribosomal RNA (1). All protein products
of the mitochondrial genome are part of the multi-subunit
complexes involved in oxidative phosphorylation.
Synthesis of these proteins is carried out on a specialized
translational apparatus located within the organelle. The
components of the mitochondrial translational machin-
ery—translational factors and mitoribosomes—are dis-
tinct from those in the cytosol and generally resemble
bacterial counterparts (2).
Our understanding of the mechanisms of mitochondrial
translation is far from complete. A limited number of
factors involved in mitochondrial translation initiation,
elongation and termination have been identiﬁed and char-
acterized (3–7). The mechanism of the last step of protein
synthesis, the disassembly of the post-termination com-
plex, has not yet been explored in human mitochondria.
Due to the monophyletic a-proteobacterial origin of
mitochondria, our knowledge of ribosome recycling in
prokaryotes can serve as a rough model for mitochondrial
processes, although it is highly likely that they will prove
to be important variations. In the bacterial system, when a
ribosome reaches a stop codon, the nascent polypeptide is
released by the coordinated actions of a sequence-speciﬁc
class I release factor (RF1 or RF2) and a sequence-
independent class II release factor [RF3, (8)]. The resulting
post-termination complex containing mRNA and deacy-
lated tRNA in the P/E site (9), has to be disassembled and
ribosomal subunits need to be recycled to initiate a new
round of protein synthesis. This process is catalysed by the
ribosome recycling factor (RRF). RRF is universally con-
served in eubacteria and deletion of the gene-encoding
RRF (frr) has been shown to be lethal for Escherichia
coli (10). Mycoplasma genitalium, with one of the smallest
genomes reported to date, retains RRF despite losing RF2
and RF3, further supporting a key role for this factor in
prokaryotic translation (11).
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has been addressed by several independent laboratories
[for example, (12–14)]. Conformational changes mediated
by RRF bound to the 70S ribosome can disrupt the inter-
subunit bridges leading to separation of the monosome.
This process requires GTP hydrolysis that is triggered by
elongation factor G (EFG). Subsequently, initiation factor
3 (IF3) binds to the 30S subunit preventing re-association
of the free subunits. More recently, emphasis has been
placed on the exact role played by bacterial RRF in this
process. Cryoelectron microscopy data on E. coli RRF
binding to 70S post-termination complexes is consistent
with a spontaneous movement of RRF from around the
peptidyltransferase centre in the monosome to a site on
the 50S subunit, resulting in the cleavage of intersubunit
bridges and subunit dissociation (15). However, no such
structural reorganization was found on X-ray crystallog-
raphy of a similar but not identical Thermus thermophilus
system (16).
To date, no human mitochondrial ribosome recycling
factor has been characterized. A candidate, mtRRF, was
proposed several years ago from bioinformatic analyses of
several overlapping EST sequences (7) but with no sup-
portive functional studies or investigation of subcellular
localization. In this article, we report that this putative
mitochondrial recycling factor is indeed a mitochondrial
protein. Furthermore, we show a direct interaction of pur-
iﬁed mtRRF with ribosomes of both bacterial and mam-
malian mitochondrial origin in vitro and in vivo. To assess
the physiological function of mtRRF, we have examined
the ability of human mtRRF to rescue yeast strains
deleted of their endogenous factor and the eﬀect of
mtRRF depletion in cultured human cells. We observed
aggregation of mitoribosomes, increased ROS and pro-
found changes in mitochondrial morphology. Our results
imply that analogous to the bacterial situation, this pro-
tein is essential for mitochondrial function and viability of
human cells.
METHODS
Tissue culturemanipulations
Human HeLa cells were cultured (378C, humidiﬁed 5%
CO2) in Eagle’s modiﬁed essential medium (Sigma-
Aldrich Co.Ltd, Dorset, UK) supplemented with 10%
(v/v) fetal calf serum (FCS), 1 non-essential amino
acids and 2mM L-glutamine. Flp-In
TMT-Rex
TM-293 cells
(HEK293T, Invitrogen Ltd, Paisley, UK) were grown in
Dulbecco’s modiﬁed Eagle’s medium (DMEM) supple-
mented with 10% FCS, 50mg/ml uridine and 1 non-
essential amino acids in the presence of 10mg/ml
Blasticidin S and 100mg/ml Zeocin (Invitrogen). Post-
transfection selection was eﬀected with Hygromycin B
(100mg/ml). For growth on respiratory substrates,
medium was glucose-free DMEM (Gibco, UK), 0.9mg/
ml galactose, 1mM sodium pyruvate, 10% (v/v) FCS,
non-essential amino acids and 2mM L-glutamine. For
growth-curve analyses, galactose medium included 50mg/
ml uridine.
Production ofGFP-, FLAG- and GST-fusion constructs
and cloning into yeast expression vectors
The original human mtRRF clone was obtained from
MGC (MGC:17776; Acc No BC013049), but primer posi-
tions described below are relative to the reference
sequence NM_138777.2.
To generate a fusion construct that would allow expres-
sion of mtRRF with GFP at the C-terminus, nucleotides
102–894 of the mtRRF cDNA were ampliﬁed using pri-
mers for 50-CACACATGATCAGATTGTCTTCAGTCA
TGG-30 and Rev 50-CACACATGATCAAGTTCTTTGG
TCTTCACTGC-30 (BclI sites underlined). This was
digested and cloned in-frame upstream of GFP in
pGFP3 (pcDNA3.1 Invitrogen, containing the GFP
open reading frame (ORF) and multiple cloning site
kindly donated by Dr D Elliott, Newcastle University).
The glutathione-S-transferase (GST)-fusion constructs
were made of the full-length (FL) or N-terminal deleted
(NDel) mtRRF. These were generated by amplifying
nucleotide 116 or nucleotides 324–940, respectively. The
FL forward primer incorporated a BclI site, whilst the
NDel included an EcoR1 site (FL for 50-CACACCTG
ATCAATGGCCTTGGGATTAAAG-30; NDel for 50-C
ACACCGAATTCCCAGAGTGAATATTAATGCT-30)
and the same reverse primer was used for both ampliﬁca-
tion reactions (Rev 50-AATTATGCGGCCGCACTGGG
CTCTGGAGTATT-30 containing a NotI site). Amplicons
and vectors were digested to allow in-frame downstream
fusion of mtRRF-GST in pGEX-6P-1 or pGEX-6P-2,
respectively (GE Healthcare, Amersham, UK).
To generate a FLAG-tagged mtRRF construct, the fol-
lowing primers were used to amplify nucleotides 115–900.
The region corresponding to the FLAG tag is italicized
and EcoRV sites are underlined for 50-CTTTCTTGATAT
CCCACCATGGCCTTGGGATTAAAGTGCTTCCGC
ATGGTCCA-30 and Rev 50-CTCTCCGATATCCTACT
TATCGTCGTCATCCTTGTAATCTCCAAGGAGTT
CTTTGG-30.
A FL mtRRF PCR product (nucleotides 101–980) was
generated using primers for 50-CACACCTGATCAGGA
UUGUCUUCAGUCAUG-30 and Rev 50-CACACCTGA
TCAGAGAGAAGTCCCAATGTGC-30 (BclI site under-
lined). This product was cloned into pGEM-Teasy
(Promega, Southampton,UK), excised by NotI digestion
and subcloned into NotI-digested Saccharomyces cerevi-
siae URA3 expression vector pFL61 (17) or the
Schizosaccharomyces pombe ura4 expression vector
pTG1754 [a gift from Transgene, (18)], which both con-
tain a strong constitutive promoter.
Transient transfection ofHeLa cells, microscopy
and image capture
HeLa cells were grown on coverslips to 50% conﬂuency,
transfected with GFP fusion vector (1mg) using SuperFect
(Qiagen, Sussex, UK) as recommended and cultured for a
further 24h prior to incubation with Mitotracker Red
CM-H2XRos (1mM ﬁnal, Invitrogen). After brief ﬁxation
(4% paraformaldehyde/PBS, 15min at room tempera-
ture), cells were mounted in Vectashield (H-1200 Vector
Laboratories Ltd, Peterborough, UK) and visualized by
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Germany) DMRA. Images were recorded as a Z-series
(0.5mm slices) using a cooled CCD camera and imaging
system (Spot–II Diagnostics Instruments, Sterling
Heights, MI, USA).
Immunocytochemistry
HeLa cells (3 10
5) plated on coverslips were incubated
with Mitotracker Red CMH2XRos, as described above,
ﬁxed in 3% paraformaldehyde, incubated with anti-
mtRRF polyclonal antibodies (1/300) for 4h, washed,
and then incubated with AlexaFluor-488 conjugated
anti-rabbit antibodies (Molecular Probes, Invitrogen,
Paisley, UK) for 1h. Signals were visualized by micro-
scopy as described above.
Mitochondrial import assays
Assays were performed and assessed using isolated rat
liver mitochondria following the methods described in
ref. (6) but with reticulocyte lysates programmed with
the relevant RNA species.
Over-expression and purification ofmtRRF–GST
Escherichia coli strain Rosetta(DE3)pLysS (Novagen,
Merck Biosciences Ltd, Nottingham, UK)
was transformed with constructs for the over-expression
of the human mitochondrial RRF. Bacteria were induced
at 0.5 A600 with 1mM IPTG, overnight at 168C. Pelleted
cells were resuspended in 50mM Tris–HCl pH7.4,
150mM NaCl, 1mM lysozyme, 1mM EDTA, 1mM
PMSF and sonicated on ice 10 10s (Soniprep 150).
Post-centrifugation (30 000g for 20min, 48C), the super-
natant was ﬁltered (0.45mm Corning) and incubated
for 3h at 48C with glutathione Sepharose 4B beads
(GE Healthcare). Beads were extensively washed prior to
elution in 50mM Tris–HCl pH 7.8, 150mM NaCl, 20mM
reduced glutathione, 1mM PMSF.
For cleavage and removal of the GST on the Sepharose,
beads were incubated at 48C overnight in 50mM Tris–
HCl pH 7.8, 150mM NaCl, 1mM PMSF supplemented
with 1mM EDTA, 1mM DTT and 24ml/ml PreScission
Protease (GE Healthcare). Eluted recombinant protein
was stored at 48C.
Production of anti-mtRRF antibodies
Recombinant human mtRRF puriﬁed as described above
was used as an antigen to raise rabbit antisera. Antibody
generation and aﬃnity puriﬁcation was performed by
Eurogentec, Belgium.
In vitro ribosome bindingassay
Escherichia coli ribosomes were prepared as described in
ref. (6). Reactions (50ml) combined puriﬁed recombinant
mtRRF69 and 70S ribosomes (1mM) in 10mM Tris–
HCl pH 7.2, 10mM Mg(OAc)2,8 0 m MN H 4Cl, 1mM
DTT at room temperature for 30min. The mixture was
centrifuged through 10% (v:v) sucrose (150ml in binding
buﬀer) for 1h in Beckman–Coulter air-driven
ultracentrifuge (30p.s.i.). Fractions (4 50ml) were col-
lected and analysed by western blot.
Stable transfection ofHEK293T cells with FLAG-tagged
mitochondrially targetedproteins
Cells were transfected at  30% conﬂuency using
Superfect (Qiagen). The vectors, pOG44 expressing FRT
recombinase, and pcDNA5/FRT/TO containing
sequences of the genes to be expressed (FLAG-tagged
mtRRF or mitochondrially targeted luciferase) were com-
bined to give a total of 2mg DNA in a 9:1 ratio, and mixed
with Superfect prior to a 3-h incubation with the cells.
Selection with Hygromycin B (100mg/ml) commenced 2
days later. Independent colonies were isolated, propagated
and analysed for induction (1mg/ml tetracycline) by wes-
tern analysis using anti-FLAG antibodies (Sigma).
Isokinetic sucrose-gradient analysis of mitochondrial
ribosomes
Total cell lysates (0.5mg) were loaded on a linear sucrose
gradient [10–30% (v:v), 1ml] in 10mM Tris–HCl pH 7.2,
10mM Mg(OAc)2,8 0m MN H 4Cl, 1mM PMSF and cen-
trifuged for 2h at 100000g at 48C. Fractions of 100ml
were collected and analysed by western blot.
Affinity purification andelution ofFLAG peptides
Mitochondria were isolated from HEK293T cells over-
expressing FLAG-mtRRF or -mtLUC essentially as
described in ref. (6) and treated with proteinase K (5mg/
1mg of mitochondria; 30min 48C) followed by PMSF
(1mM) inhibition. Pelleted mitochondria were resus-
pended in lysis buﬀer (supplemented with 10mM
Mg(OAC)2 as indicated, although no diﬀerence in the
composition of protein precipitate could be measured
without supplement). Immunoprecipitation was per-
formed with a-FLAG-Gel following manufacturer’s
recommendations (Sigma Aldrich, St Louis, MO, USA).
Elution was eﬀected with FLAG peptide. RNase A (5mg/
ml) and EDTA (50mM) were added as indicated.
Massspectrometry analysis and protein identification
Mass spectrometric analysis of immunoprecipitated com-
plexes was performed as described in Supplementary
Material.
Yeastgrowth conditions, plasmid and generalstrain
constructions and complementation assays
All yeast strains used in this study are detailed in Table S2.
General yeast media and genetic techniques/transforma-
tion protocols were as described in ref. (18). In brief, fer-
mentable media contained 2% glucose, non-fermentable
conditions were 3% (v:v) glycerol/ethanol or 2% (v:v)
glycerol with 0.1% glucose or for S. pombe only 2%
(w:v) galactose/0.1% (w:v) glucose.
Production of S. pombe "rrf1 strain
A single S. pombe protein, encoded by the gene
SPBC1709.09, was found to have signiﬁcant similarities
to both S. cerevisiae Rrf1 (Figure S4) and E. coli RRF.
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cloned into the NotI site of the pTG1754 and pFL61
expression plasmids for S. pombe and S. cerevisiae, respec-
tively. An S. pombe Drrf1::Kan
R strain (NB331) was con-
structed in the wild-type recipient strain NB205-6A by
using a PCR disruption strategy with hybrid rrf1-Kan
R
oligonucleotides as described in ref. (19), removing
629bp encompassing the 735bp rrf1Sp ORF (starting
8bp before the ATG). Of 50, 22 clones showed delayed
growth on glycerol medium and were proved to contain
the correct insertion by PCR. Crossing to wild-type fol-
lowed by sporulation and tetrad analysis showed a 2:2
cosegregation of the geneticin resistance and slow glycerol
growth. Transformation with the Rrf1pSp-encoding plas-
mid restored growth on galactose, conﬁrming that the
mitochondrial DNA was intact in this strain.
Spectroscopic analyses
Cells from Drrf1Sp transformants were dried, mixed
with sodium dithionite to fully reduce the cytochromes
and frozen in liquid nitrogen before recording the
absorbance of the samples at wavelengths from 630nm
to 490nm (spectrophotometer Cary 400O ` , Varian, San
Fernando, CA). Peaks were the following: cytochrome c
(548nm), cytochrome c1 (554nm), cytochrome b (560nm)
and cytochrome aa3 (603nm).
siRNA constructs, transfection andRT–PCR analysis
The following sequences targeting mtRRF were tested for
eﬃciency of mRNA and protein depletion. Nucleotide
positions are relative to reference sequence NM_
138777.2, siRNA ORF1 50 GGACACCAUUAGGCUA
AUA dTdT 30 (nucleotides 211–229); siRNA ORF2 50
GAGAAAUGCUGGUGAAACU dTdT 30 (nucleotides
684–702); siRNA ORF3 50 GACAGUGCAUGAAAGA
CAA dTdT 30 (nucleotides 799–817). Experiments were
performed with siRNA ORF2 unless otherwise speciﬁed.
Treatment of stably transfected and induced HEK293T
cells was performed with siRNA UTR1 50 GUAUUC
UUGUUGCACUUAA dTdT 30 (nucleotides 1633–1651)
targeting the 30-UTR region that was absent in the indu-
cibly expressed form of mtRRF. Transfections were per-
formed on 20% conﬂuent cells with Oligofectamine
(Invitrogen) in Optimem-I medium (Gibco) with ﬁnal con-
centrations of 0.2mM siRNA. Control non-targetting
siRNA and custom siRNA duplexes were purchased, pur-
iﬁed and pre-annealed from Eurogentec. Quantiﬁcation
of mtRRF mRNA was performed with TaqMan
Gene Expression Assay (Applied Biosystems,
Warrington, UK) using ABI Prism sequence detector
system. Data were normalized to GAPDH as an endogen-
ous control. Probe kits were ordered from Applied
Biosystems—HS01067555_g1 (mtRRF) and
HS999999905_m1 (GAPDH).
Cellpreparations, western analysis andBlue Native-PAGE
Schizosaccharomyces pombe mitochondria was puriﬁed
from cells grown either in complete glucose medium or
in minimal glucose medium lacking uracil as described
in ref. (19) with Roche protease inhibitors present at all
stages. Yeast proteins were separated by 12% SDS–PAGE
and immobilized on nitrocellulose (Schleicher & Schuell,
London, UK) by wet transfer in 25mM Tris, 192mM
glycine, 0.02% (w/v) SDS and 20% (v/v) ethanol. Blots
were hybridized with mouse (anti-human Hsp60, Sigma
H-3525; anti-FLAG, Sigma H-1804) or rabbit antibodies
[anti-mtRRFHs (this work); -Cox2Sp, (20) -Arg8Sc (21); -
EFTuSp (18)].
Human cell lysates were prepared, separated by
SDS–PAGE and immobilized by wet transfer as
described (6). Proteins of interest were bound by overnight
incubation (48C) with antibodies [mtRRF, GDH
(Lightowlers Group, Newcastle); Porin, COX I, COX II,
SDH 70K and ND6 (MitoSciences, Eugene, OR); b-actin
(Sigma); DAP3, MRLP3 (Abcam, Cambridge, UK)] fol-
lowed by HRP-conjugated secondary antibodies (DAKO)
and visualized by ECL-plus (GE Healthcare).
Blue native gel electrophoresis was performed as
described in ref. (22) with 30mg protein loaded per lane
and wet transfer as above.
Free radicals and mitochondrial mass measurements
MitoSOX (Molecular Probes) prepared in DMSO,
diluted to 5mM in DMEM medium-lacking serum was
added to cells for 10min at 378C. Cells were washed
before re-suspension in 2ml DMEM-lacking serum and
passed through a FACScan ﬂow cytometer (Becton
Dickinson Ltd, Oxford, UK, equipped with 488nm
Argon laser). Data were collected for forward and side
scatter together with autoﬂuorescence of unstained cells,
gating eliminated debris and apoptotic cells from the ana-
lyses. After acquisition, data were analysed by WinMDI
software (version 2.8). Experiments were performed on
four independent occasions with triplicate measurements
based on 10000 events. Dihydrorhodamine 123 (DHR,
Molecular Probes) and nonyl acridine orange (NAO,
Molecular Probes) were resuspended in DMSO, diluted
to 30mM (DHR) or 10mM (NAO) in DMEM-lacking
serum and incubated with cells at 378C for 30 (DHR)
min or 10 (NAO) min. Cells were then washed before
resuspension in 2ml DMEM-lacking serum and green
ﬂuorescence emission analysed as above.
Electron microscopy studies
Cells were grown as detailed above, pelleted and ﬁxed in
2% glutaraldehyde in Sorensen’s phosphate buﬀer.
Samples were than post-ﬁxed in 1% osmium tetroxide in
the same buﬀer, dehydrated in alcohol and embedded in
Epoxy resin (TAAB). Ultrathin sections were stained with
2% aqueous uranyl acetate and lead citrate and examined
using a Philips CM100 transmission electron microscope
(EM Research Services, Newcastle University).
In vivomitochondrial protein synthesis
Protein translation in HeLa cells was performed essen-
tially as described (23). Cells were incubated with radiola-
belled methionine for 15min.
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High-resolution respirometry was performed at 378C with
an Oroboros Oxygraph-2K (Oroboros Instruments,
Austria) essentially as detailed in ref. (6).
Statistical analysis
Students unpaired t-tests were used to determine the
signiﬁcance of values as indicated in the ﬁgure legends.
Values of P<0.05 were recorded as statistically
signiﬁcant.
RESULTS
MtRRF, the human homologue ofbacterial RRF,
is amitochondrial protein
To conﬁrm mitochondrial localization of the putative
human mtRRF predicted by in silico studies (7), a
mtRRF–GFP fusion construct was used to transfect
HeLa cells. This chimera included all but the terminal 2
residues of mtRRF fused N-terminal to GFP. Cells were
cultured for 24h prior to staining with Mitotracker CM-
H2XRos, to visualize mitochondria. Fluorescence micro-
scopy images and line scan analysis (Figure 1A, left
panels) of transfected cells demonstrated co-localization
of mtRRF–GFP with Mitotracker Red. In contrast to
the well-deﬁned, discrete pattern produced by mtRRF–
GFP, expression of the GFP protein alone produced a
diﬀuse stain (data not shown).
To verify, if localization of the mtRRF–GFP fusion
protein reﬂects the behaviour of the endogenous protein,
immunocytochemistry was performed. Polyclonal antisera
against FL recombinant protein were raised and anti-
mtRRF antibodies aﬃnity were puriﬁed. Immunocyto-
chemistry (Figure 1A, right panels) indicated similar mito-
chondrial localization of both the endogenous and
mtRRF–GFP.
To conﬁrm that mtRRF is indeed imported into the
mitochondrial matrix and not merely localized to the
organelle, import assays were performed with isolated
Figure 1. mtRRF is a mitochondrial protein with an extended N-terminal pre-sequence. (A) Human mtRRF is targeted to mitochondria. Left panels
show HeLa cells transiently transfected (24h) with a mtRRF–GFP fusion construct. Cells were stained to visualize nuclei (DAPI blue) and
mitochondria (Mitotracker red). Fluorescence images and linescans conﬁrmed mitochondrial localization of mtRRF–GFP by superimposition of
green and red signals (lower left). The image reﬂects three-independent transfections. Endogenous mtRRF in HeLa cells was visualized by immu-
nocytochemistry (upper right) using aﬃnity puriﬁed anti-mtRRF and FITC secondary. DAPI-stained nuclei (blue) and Mitotracker the mitochondria
(red). Mitochondrial localization of mtRRF was conﬁrmed by superimposition of linescan green and red ﬂuorescence (lower right). The image
reﬂects three-independent transfections. (B) Human mtRRF is imported into mitochondria. FL
35S-radiolabelled mtRRF was in vitro synthesized and
incubated with rat liver mitochondria (lane 1). Under import conditions a single product is visible (lane 2) that is protected from proteinase K
(lane 3), but degraded by treatment with proteinase K and FCCP uncoupler (lane 4). Control import reactions contained DHFR with a mitochon-
drial pre-sequence (Su9) showing the FL pre-protein and the matured form under import conditions. (C) Sequence alignment (CLUSTALW)
indicates an extensive N-terminal pre-sequence when compared with E. coli or Thermotoga maritima. Identity to these RRFs is indicated in blue
and by
 , high levels of similarity by a colon ‘:’ and lower levels by a fullstop ‘.’.
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35S-labelled mtRRF
(Figure 1B). Resistance of the radiolabelled protein to
proteinase K (lane 2) conﬁrmed successful mitochondrial
uptake. Import resulted in cleavage of the mitochondrial
targeting pre-sequence of Su9-DHFR but interestingly not
of mtRRF. This is consistent with bioinformatic predic-
tions (www.cbs.dtu.dk/services/TargetP) being unable to
identify a clear cleavage signal in the mtRRF sequence
(7). Alignment of the mtRRF sequence with bacterial
counterparts indicates that optimal alignment begins at
position 80 of the FL mtRRF (Figure 1C). Since our
results show that this long N-terminal extension is not
a cleavable import signal but an integral part of the
mature protein, it suggests that it may be of functional
importance speciﬁc to mitochondria.
mtRRF binds E. coli ribosomesin vitro and canassociate
withhuman mitoribosomes
Direct interaction of prokaryotic RRF with ribosomes in
the absence of other translation factors has been demon-
strated (16,24). Binding experiments were therefore per-
formed to determine if human mtRRF could play a
similar role to its bacterial homologues. Isolation of FL
over-expressed mtRRF showed that the protein tended
to aggregate (Figure S1). Therefore, a short N-terminal
truncation mtRRF69 was used as this deletion signiﬁ-
cantly increased solubility of the recombinant protein.
Comparative circular dichroism analysis of both the FL
and truncated mtRRF conﬁrmed that removal of the
N-terminus did not cause any major structural changes
(data not shown). In vitro binding assays showed that
mtRRF localized to the rapidly sedimenting ribosomal
fraction only in the presence of E. coli ribosomes
(Figure 2A), indicating a direct interaction.
To determine whether mtRRF could interact with
mitoribosomes in isolated organelles, FLAG epitope-
tagged mtRRF was inducibly expressed in human
Flip-In T-REx HEK293 cells (HEK293T) as described
in procedures. Subsequently, complexes containing the
fusion protein were isolated from solubilized mitochon-
dria by anti-FLAG aﬃnity puriﬁcation and FLAG pep-
tide elution. To control for non-speciﬁc binding, FLAG-
tagged mitochondrially targeted luciferase (mtluc) was
expressed in cells and immunoprecipitated by the same
procedure. Western analysis revealed a speciﬁc interaction
of mtRRF and mitoribosomal proteins (Figure 2B).
Mitoribosomes were very eﬃciently precipitated with
FLAG-mtRRF. Taken together these data show that
mtRRF can tightly associate with mitoribosomes.
Bacterial RRF is only transiently associated with ribo-
somes in vivo, partially occluding the P and A sites on
binding to the post-termination complex (9,15) so it was
surprising to ﬁnd that the majority of mtRRF was bound
to mitoribosomes. To investigate this further, HEK293T
cells were induced as above and lysates were immediately
subjected to isokinetic sucrose-gradient centrifugation.
This mtRRF over-expression was not deleterious to cell
growth (data not shown) but led to a slight decrease in
mitoribosome formation (Figure 2C cf. Figure 5A). No
association of mtRRF with mitoribosomes at steady
state was detectable. However, binding became evident
on incubation (3h) of the lysate prior to centrifugation
(mimicking the IP procedure) potentially due to dissocia-
tion or hydrolysis of charged tRNAs that would naturally
occupy most A/P sites. This dependence on pre-incubation
was not a consequence of mtRRF over-expression, as a
similar eﬀect was noted with HeLa cell lysate (Figure 5A,
data not shown). Further, association was not due to non-
speciﬁc interactions promoted by the pre-incubation step
as interactions were lost either on RNase or EDTA treat-
ment (Figure 2E, lanes 1 and 2).
Mitoribosomes associated withnumerous mitochondrial
proteins are co-immunoprecipitated withmtRRF
Immunoprecipitation (IP) experiments using mtRRF as
bait revealed an association with two mitoribosomal pro-
teins, presumably indicating the presence of the large (39S)
and small (28S) ribosomal subunits (MRPs) (Figure 2B).
To conﬁrm the presence of other MRPs and determine
which if any additional proteins were present, IP experi-
ments were performed on lysates from a protease/DNase-
treated HEK293T mitoplast fraction. After elution of spe-
ciﬁcally bound proteins with FLAG peptide, the eluant
was separated by gel electrophoresis and gel slices sub-
jected to LC-MS/MS as detailed in Supplementary
Material. The mitoplast enrichment procedure yielded a
total of 167 identiﬁed mitochondrial proteins (Tables 1
and S1), 73 of which were indeed MRPs. Although
MRPs constituted most of the puriﬁed immunoprecipi-
tated proteins, detailed LC-MS/MS analysis revealed
some remaining cytosolic contaminants (data available
on request) but also allowed us to identify other mito-
chondrial proteins that co-immunoprecipitated with
mtRRF (Table 1). The second largest group were proteins
that had been previously reported as components of
human mitochondrial nucleoids (25–27). Among other
proteins interacting with mitoribosomes were factors
involved in intra-organellar translation, nucleic acid bind-
ing proteins and chaperones/proteases, all proteins that
might be expected to associate with ribosomal compo-
nents or nascent peptides. Several polypeptides known
to be involved in metabolism were also identiﬁed.
Human mtRRF improves the respiratory competence of
S. pombe "rrf1
To gain insight into the in vivo function of human mtRRF,
we ﬁrst examined whether it could replace the endogenous
mtRRF of the budding yeast S. cerevisiae. Respiratory
deﬁciency due to loss of S. cerevisiae mtRRF (rrf1Sc)
was reportedly associated with depletion of cytochrome c
oxidase activity (28) or total loss of mtDNA (29). Thus,
for complementation analysis we used rrf1Sc strains
with diﬀerent nuclear and mitochondrial backgrounds
(Supplementary Material). In the W303 background,
rrf1Sc cells showed a mild to pronounced respiratory
deﬁciency depending on the mitochondrial intron content
(Figure S2), but retained wild-type mtDNA. This allowed
direct complementation tests by transformation with
expression plasmids carrying either the natural S. cerevi-
siae gene, or human or S. pombe (ﬁssion yeast)
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human homologue complemented the S. cerevisiae
mutant (Figure 3A, data not shown).
As the ﬁssion yeast S. pombe is regarded as a closer
evolutionary relative to human than S. cerevisiae,
particularly in mitochondrial physiology (19), we inacti-
vated the gene coding the S. pombe mtRRF homologue
(rrf1Sp) to test if it could be replaced by human mtRRF.
Deletion of rrf1Sp slightly but signiﬁcantly impaired
growth on non-fermentable carbon sources (Figure 3B),
Figure 2. Human mtRRF associates with bacterial ribosomes in vitro and mitoribosomes in vivo.( A) Human mtRRF binds E. coli ribosomes.
Recombinant mtRRF (mtRRF69) was incubated with or without 70S ribosomes prior to sedimentation through 10% (w:v) sucrose. Fractions were
subjected to western analysis. (B) mtRRF associates with mitoribosomes. FLAG-mtRRF and mtLuc HEK293T cells were induced, mitochondria
isolated. Lysate was prepared (lane 1) from which proteins were immunoprecipitated via the FLAG epitope (lanes 2–3). Western blot analysis used
antibodies to mtRRF, large 39S and small 28S mitoribosomal subunits (MRPL3, DAP3), mitochondrial chaperone (mtHSP70), complex IV (COX 2)
and a matrix protein (glutamate dehydrogenase -GDH). (C) Pre-incubation of mitochondria allows detection of mtRRF binding to mitoribosomes.
Lysate was prepared from HEK293T cells after induction of FLAG-mtRRF and was either separated immediately or post 3h incubation on a
10–30% (v:v) isokinetic sucrose gradient. Fractions were analysed by western blot with antibodies to mtRRF, MRPL3 (39S mitoribosomal subunit)
or DAP3 (28S mitoribosomal subunit). A similar time-dependent mitoribosomal association in HeLa cell lysate was noted for the endogenous
mtRRF (data not shown). (D) HEK293T cells were induced ( Tet) for FLAG-mtRRF (lanes 1–2) or control mtluc (lane 3) expression and
mitochondria isolated. Co-immunoprecipitating proteins were separated through a 12% SDS–PAG and visualized by silver stain. mtRRF, mtluc
and anti-FLAG IgG are indicated. (E) Preparations of the mtRRF IP were also treated with EDTA (lane 1) or RNase A (lane 2). Mitochondrial
lysate is shown in lane 3.
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(Figure 3C) and decreased steady-state levels of mt-
encoded Cox2 protein (Figure 3D), consistent with a
role in mitochondrial translation. In addition, western
analysis of S. pombe mtRRF protein conﬁrmed mitochon-
drial location (Figure S3). Transfectants of this strain
expressing FL human mtRRF were able to fully restore
normal growth on non-fermentable medium, levels of mt-
encoded cytochromes and Cox2 protein, correlating with
weak but reproducibly detectable mtRRFHs in only the
mitochondrial fraction (Figure 3B–D). Thus, human
mtRRF clearly performs the same function as S. pombe
mtRRF consistent with interaction with the S. pombe
mitochondrial translation machinery.
Lossof mtRRF inhuman cells results inreduced growth rate
andcell death
To determine the function of mtRRF in human mitochon-
dria, three siRNA speciﬁc to the human mtRRF mRNA
were designed and used to transfect HeLa and HEK293T
cells. A non-targeting siRNA (NT) was used to conﬁrm
speciﬁcity. A reduction of 80–90% of mtRRF mRNA
levels were observed 2 days post-transfection with a con-
sequent dramatic reduction in mtRRF protein by day 3
(Figure 4A). To investigate the long-term eﬀect of mtRRF
depletion, HeLa cells were retransfected with siRNA on
the third day of the experiment. Interestingly, the cells
transfected with mtRRF siRNA(ORF2) showed a signiﬁ-
cant reduction in growth compared to NT controls
(Figure 4B). After 3 days of mtRRF siRNA treatment,
cells developed morphological changes and depletion for
more than 6 days was lethal. If cells were cultured in
glucose-free media supplemented with galactose to force
dependence on oxidative phosphorylation, the eﬀect of
mtRRF depletion was even more profound (Figure 4B).
These observations suggest that mtRRF is an essential
protein and its loss aﬀects mitochondrial functions.
To further ensure that the growth phenotype was spe-
ciﬁc to mtRRF depletion, an siRNA designed against the
30-UTR of mtRRF was introduced to HEK293T cells,
concomitant with inducible expression of the exogenous
FLAG-mtRRF lacking this 30-UTR. Expression of mtRRF
after transfection of the cells with 30-UTR-speciﬁc mtRRF
siRNA restored normal growth (Figure 4B) consistent
with the growth phenotype being solely due to depletion
of mtRRF.
Depletion ofmtRRF partially affects mitochondrial
translation and inhibits mitoribosomal disassembly
What is the mechanism causing the growth phenotype? It
has been shown that in bacteria and yeast mitochondria,
inactivation of RRF inhibits protein synthesis (12,29). To
determine if the same is true for the mtRRF, we investi-
gated the eﬀect of protein depletion on an in vivo mito-
chondrial protein synthesis. In the presence of mtRRF
siRNA, there was partial inhibition of mitochondrial pro-
tein translation (Figure 4C). Although the eﬀect was not
as dramatic as in S. cerevisiae Drrf1 (29), it must be recog-
nized that even partial translation defects result in instabil-
ity and loss of mtDNA, which in turn produce a greater
impairment of mitochondrial protein synthesis. The rela-
tive synthesis of most of the components was signiﬁcantly
altered (Figure 4C, data not shown). Consequently, the
steady-state levels of mtDNA-encoded proteins were pro-
gressively aﬀected as detected by western blot (Figure 4D).
Although we did not observe signiﬁcant reduction of the
protein levels after short siRNA treatment (2–3 days),
longer treatment resulted in decreased steady-state levels
of mitochondrially encoded proteins of up to 40% when
compared to non-targeting controls (day 6). These results
were consistent with the decreased levels of fully
assembled OXPHOS complexes after 6 days siRNA treat-
ment, as revealed by Blue Native gel electrophoresis
(Figure 4E). Moreover, polarographic measurements
showed that respiration rates of the siRNA-treated cells
decreased, consistent with aﬀected function of OXPHOS
complexes (Figure 4F).
To further decipher the exact mechanism of mtRRF
function in mitochondrial translation, we looked at the
sedimentation proﬁle of HeLa cell mitoribosomes in iso-
kinetic sucrose density gradients following mtRRF deple-
tion. Western analysis of mitoribosomes from cells treated
for 4 days with NT or mtRRF siRNA (Figure 5A) showed
a striking contrast in distribution of DAP3 representing
the small ribosomal subunit. mtRRF siRNA caused a shift
from fractions 5–8 to mainly 7. This fraction has proteins
Table 1. Predicted function of the mitochondrial proteins identiﬁed
after anti-FLAG mtRRF aﬃnity precipitation
Protein type
a Immunoprecipitation
mtRRF
b mtRRF+EDTA
c mtRRF+RNase
d
Mitoribosomal
proteins
e
73 1 0
Nucleoid
f
Class I 25 (31) 2 0
Class II 6 (10) 0 0
Class III 6 (16) 0 0
Nucleoid
g 5 (6) 1 0
Translation
associated
61
h 1
h
Nucleic acid
binding/modifying
13 0 0
Metabolic 23 0 0
Chaperone/protease 5 0 0
Transporter 4 0 0
Unknown function 6 0 0
TOTAL 167
j 7
i 1
aKnown or predicted function of identiﬁed mitochondrial proteins.
bImmunoprecipitation from mitoplasts after protease and DNase
shaving.
cEDTA-washed immunoprecipitant from crude mitochondria.
dRNase-treated immunoprecipitant from crude mitochondria.
eMitoribosomal subunits identiﬁed by Koc et al. 2001 (39) and Cavdar
Koc et al. (40).
fPutative nucleoid proteins as recently classiﬁed by Bogenhagen et al.
(25) (of total proteins).
gPutative nucleoid proteins as identiﬁed by He et al. (26) (of total
proteins).
hMitochondrial ribosomal recycling factor, mtRRF.
iThree cytosolic ribosomal proteins were identiﬁed in the precipitation
following EDTA treatment.
jDoes not include any non-mitochondrial, hypothetical or predicted
proteins that were found.
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sents monosome accumulation. Moreover, only after
mtRRF depletion where both ribosomal subunits detected
in the heaviest fraction (F11), suggesting aggregation of
the ribosomal proteins. We conclude that on depletion of
mtRRF, monosomes are poorly dissociated into single
subunits and non-functional monosomes accumulate, pro-
ducing aggregates. These data are consistent with mtRRF
functioning as a factor responsible for disassembly of ribo-
somes in human mitochondria.
Depletion ofmtRRF causes increased mitochondrial
ROS and changes in mitochondrial morphology
The observed aggregation of mitoribosomes may have a
direct inﬂuence on mitochondrial function and may be a
primary cause of cell death. Stress conditions in mitochon-
dria are frequently associated with elevated levels of reac-
tive oxygen species (ROS). To assess stress due to ROS
accumulation in siRNA-treated cells, superoxide and
peroxide/peroxynitrite levels were measured by mitoSOX
and DHR, respectively. A statistically signiﬁcant increase
of ROS levels over the NT control was seen at day 3, a
diﬀerence that was maintained through to day 6
(Figure 5B).
Increased ROS is often paralleled by augmented mito-
chondrial biogenesis and mtRRF depletion also resulted
in a signiﬁcant increase of mitochondrial mass as mea-
sured by NAO ﬂuorescence, a dye that binds selectively
to cardiolipin in the mitochondrial inner membrane
(Figure 5B).
These abnormalities were reﬂected in the progressive
morphological changes of mitochondria revealed by EM
(Figure 5C 3 days and 6 days mtRRF siRNA) where the
longer treatment resulted in a dramatic increase in mito-
chondrial density. Many more tightly packed membra-
nous sheets were observed, which was consistent with
increased mitochondrial biogenesis, whereas the numerous
‘black spots’ detected in the matrix compartment are con-
sistent with mitoribosome aggregates.
Figure 3. Human mtRRF suppresses a partial respiratory deﬁciency in Drrf1 ﬁssion yeast. (A) Human mtRRF cannot rescue the rrf respiratory
defect in budding yeast. Saccharomyces cerevisiae transformants of Drrf1 strain MG38 carrying the control vector pFL44L or URA3 plasmids
producing the S. cerevisiae, S. pombe or human mtRRF were replica-plated on non-fermentable media (eth/gly + glycerol 0.1% glucose) and
incubated at 288C. (B–D) Human mtRRF restores respiratory capacity in rrf1 ﬁssion yeast. Schizosaccharomyces pombe lacking endogenous RRF
(rrf1Sp, NB331) was transformed with vector alone (vector) or expressing human (RRFHs) or S. pombe (RRFSp) mtRRF (B). Serial dilutions of
three rrf1Sp transformants were spotted on complete glucose, uracil-free minimal or complete gly/eth media and grown at 288C for the times
indicated. (C) rrf1Sp transformants were grown on 2% glycerol/0.1% glucose (vector) or ethanol/glycerol medium (RRFSp or RRFHs) before
recording whole-cell cytochrome spectra. Cytochrome b+c1 and aa3 correspond to Complex III and Complex IV, respectively. (D) Mitochondria
and post-mitochondrial supernatants from transformants grown in glucose medium minus uracil were separated by 12% PAGE and analysed by
western blot with antibodies recognizing human mtRRF, S. pombe mtEF-Tu and mt-encoded Cox2, human mt-Hsp60 and S. cerevisiae mtArg8 (this
also recognizes S. pombe Arg1 in mitochondria and an unknown protein in the supernatant).
Nucleic Acids Research, 2008, Vol. 36, No. 18 5795Figure 4. Depletion of human mtRRF severely aﬀects cell viability and compromises mitochondrial translation. (A) siRNA-mediated depletion of
human mtRRF. HeLa cells were exposed to three diﬀerent siRNA molecules all in the mtRRF-coding sequence or an control siRNA for 6 days and
RNA or cell lysates were prepared. Levels of mtRRF transcript compared to control siRNA transfected cells were quantiﬁed by real-time PCR
(upper graph, mean   SEM from four-independent transfections). Western blots (30mg lysate/lane) in the lower panel were performed with
antibodies against mtRRF to conﬁrm depletion and b-actin as a loading. The blot accurately reﬂects three experiments. (B) Depletion of mtRRF
causes a severe growth defect. Multiple aliquots of HeLa cells (left and centre panels) were exposed to targeted (mtRRF, open triangles) or non-
targeted (NT, black squares) siRNA for 6 days in glucose (left) or galactose (centre) media, cells counted and presented in a semi-log plot. Counts
were made of HEK293T transfectants (right panel) treated with non-targeted siRNA (NT, black squares) or siRNA directed against the endogenous
mtRRF 30-UTR with (open circles) or without (open triangles) concomitant inducible expression of FLAG-mtRRF. Numbers are a mean   SEM of
four independent wells. (C) In vivo mitochondrial proteins synthesis is partially aﬀected by mtRRF depletion. HeLa cells were grown in the presence
of control (NT) or targeted (mtRRF) siRNA. Cytosolic protein synthesis was inhibited with emetine prior to labelling mitochondrial proteins with
35S-methionine (15min). Equal amounts of lysate (20mg) were separated by 15% SDS–PAGE and gels analysed by PhosphorImager. Polypeptides
designation is as described in ref. (23). (D) Steady-state levels of mtDNA-encoded proteins are aﬀected by depletion of mtRRF. Western blots show
analysis of cell lysates after 3 or 6 days siRNA treatment (mtRRF or NT) with antibodies against mitochondrial translation products or proteins
sensitive to mitochondrial translation inhibition (cytochrome c oxidase subunits I and II—COX I and 2; complex I subunit NDUFB8) or nuclear-
encoded complex II SDH 70kDa protein and b-actin as a loading control. The blot accurately reﬂects three repeat experiments. (E) OXPHOS
complexes are reduced at steady-state levels after mtRRF depletion. HeLa cells were exposed (6 days) to mtRRF- or NT-targeted siRNA prior to
BN–PAGE. Complexes were visualized with antisera to complex I, anti-39kDa; complex II, anti-SDH 70kDa; complex III, anti-core 2, complex IV,
anti-COII. The blot accurately reﬂects three experiments. SDH is a complex only comprising proteins encoded in the cytosol. (F) Respiratory
coupling is modestly aﬀected in cells depleted of human mtRRF. HeLa cells were exposed (3 days) to mtRRF-or NT-targeted siRNA prior to high
resolution respirometry (as in Methods), three measures of respiratory control and capacity were made.
5796 Nucleic Acids Research, 2008, Vol. 36, No. 18DISCUSSION
Our studies presented here provide the ﬁrst evidence that
this candidate functions as the human mitochondrial ribo-
some recycling factor: (i) mtRRF is a mitochondrial pro-
tein, (ii) mtRRF is able to bind bacterial ribosomes in vitro
and can tightly associate with human mitoribosomes
in vivo, (iii) expression of human mtRRF suppresses the
partial rrf1 respiratory deﬁciency in ﬁssion yeast in vivo
and (iv) upon depletion of mtRRF, the relative level of
mitochondrial monosomes increases whereas the free ribo-
somal subunits are reduced, indicating a defect in ribo-
some disassembly as has previously been reported on
depletion of the bacterial counterpart (12).
Our results show that although mtRRF can associate
tightly with mitoribosomes, the amount of interaction is
enormously increased by pre-incubation. There are many
possible hypotheses to explain this observation, but it is
interesting to note that high resolution studies have shown
Figure 5. Reduction of mtRRF results in redistribution of ribosomal proteins, increased ROS and mitochondrial dysmorphism. (A). HeLa lysates
were prepared from cells treated with mtRRF or non-targeted (NT) siRNA (3 days). After separation through 10–30% sucrose gradients, fractions
were analysed by western blot using antibodies against the small (DAP3) and large (MRPL3) mitochondrial ribosomal subunits, mtRRF, porin as a
mitochondrial membrane marker and glutamate dehydrogenase (GDH, matrix). (B) Superoxide levels are increased after mtRRF depletion. HeLa
cells were exposed to mtRRF (white) or non-targeted (NT, black) siRNA over 6 days and superoxide and peroxide levels were measured with
mitoSOX (superoxide) or DHR (peroxide) and compared to untreated controls. The fold increase is shown as a mean   SEM from minimally three
repeat experiments. Mitochondrial mass per cell was also measured using the cardiolipin selective dye NAO. (C) HeLa cells depleted of mtRRF show
altered morphology. EM micrographs show HeLa cells treated with mtRRF (3 and 6 days) or non-targeted (NT, 3 days) siRNA. The images reﬂect
mitochondria from two preparations.
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ratchet conformation at a site spanning both P and A site
(15). Therefore, it may be speculated that tRNA bound to
these sites may prevent interaction with mtRRF allowing
occupancy only when these sites become vacant.
Why does expression of human mtRRF restore the
respiratory function of an rrf1 mutant only in S. pombe
and not in S. cerevisiae? Human mtRRF shows a stronger
identity to S. pombe than the S. cerevisiae orthologue (EBI
tools 21.1% versus 16.8%; Figure S4). There is an overall
greater similarity between ﬁssion yeast and human
mtRNAs (30) and these two species share a highly con-
served set of general translation factors (18). In bacterial
systems, functional studies with heterologous RRF
and EFG proteins showed poor activity on the post-
termination ribosomal complex compared to assays
using RRF and EFG from the same species, underlining
the importance of interplay between RRF and EFG [for
example, (31,32)]. In light of these ﬁndings, it is also pos-
sible that human mtRRF was unable to rescue the growth
phenotype of S. cerevisiae rrf1 due to a weak interaction
with the budding yeast 70S mitoribosome or mtEFG that
also has only limited similarity with the human mtEFG.
Depletion experiments revealed that mtRRF is essential
for cell viability, with depletion causing gross mitochon-
drial dysmorphology and dysfunction. One of the primary
eﬀects of mtRRF depletion, which seemed to precede
measurable translation abnormalities, was elevated ROS
production (evident by day two post-transfection). The
mechanisms that lead to mitochondrial ROS overproduc-
tion, although often associated with mitochondrial dys-
function are not always clear. Our recent work on
depletion of the mitochondrial release factor mtRF1a
also resulted in a profound increase in mitochondrial
ROS without any measurable eﬀect on mitochondrial
translation (6). It is possible that increased ROS produc-
tion could be a direct result of mitoribosome aggregation,
but other subtle indirect eﬀects cannot be ruled out. Our
results are another example that even a small disruption of
interplay between mitochondrial translation, respiration
and ROS production may lead to profound cellular
dysfunction.
In this study, lack of ribosome recycling led to a variety
of deleterious downstream consequences. Shortage of
available functionally active mitoribosomes eventually
aﬀected translation, and subsequently resulted in
decreased steady-state levels of mitochondrially encoded
proteins, hence reduced amounts of fully assembled com-
plexes (6 days post-transfection). It was surprising, how-
ever, that a measurable decrease in mitochondrial protein
synthesis took so long to manifest. It is possible that
mitoribosomes are in excess in human organelles (33)
with translation being initiated by mitoribosomes that
had spontaneously disassembled. A similar process could
explain the partial growth defect in yeasts lacking RRF.
Another intriguing explanation could be that translation
may be able to initiate from monosomes that have termi-
nated translation, processed back along the mt-mRNA in
a3 0 to 50manner to reach the 50-terminus and then scanned
to locate the closest initiation codon, all without the
monosome being dissociated. Although controversial, it
must be considered that there is currently no model to
explain how the mitoribosome naturally locates to the
mt-mRNA initiation codon in the absence of a 50-cap or
Shine–Dalgarno sequence.
Finally, proteomic analysis of the factors that were
eluted from immunoprecipitated mtRRF-FLAG, revealed
73 MRPs, several translation-associated factors and puta-
tive nucleoid proteins on the production and protease/
DNase treatment of mitoplasts (Table 1). Nucleoids are
dynamic structures containing mtDNA and proteins
involved in maintenance, replication and transcription of
the mitochondrial genome [reviewed in (34)]. These struc-
tures are well described in bacteria and close association
between nucleoids and ribosomes has been previously
measured in the Gram positive bacteria Bacillus subtilis,
with this association being dependent on active transcrip-
tion (35). Coupling of transcription and translation in
human mitochondria has been frequently suggested
(36,37), but there has been only one report showing inter-
action of mtRNA polymerase with a mitoribosomal pro-
tein, MRPL12, an interaction that was shown in vitro to
stimulate transcription (38). In a recent report on proteins
associated with nucleoids, 15 mitoribosomal proteins were
identiﬁed, along with assorted factors that also function in
protein synthesis (25). This observation is consistent with
our data, but the authors were concerned that MRPs may
have been present due to adventitious co-puriﬁcation.
Such a criticism could also be levelled at our observation,
particularly as we were unable to completely remove cyto-
solic contamination, even in the mitoplasting experiments.
Without further experimentation, this remains only tenta-
tive evidence of a direct physical link between mitoribo-
some and nucleoid. However, these proteomic studies also
revealed several other candidate proteins that may be
associated with the translational machinery and/or
nucleoids. These ﬁndings open exciting avenues for further
investigations.
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